
TCR2 Therapeutics Inc.
USD1.48
+0.00 (+0.00%)
CEO
Garry E. Menzel
IPO Date
2019-02-14
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.58
Prev. Close
$1.48
Day Low
$1.48
Day High
$1.48
52W Low
$0.82
52W High
$3.88
Market Cap
$0.06B
Volume
3.75M
| 7 Mar 2023 |
| HC Wainwright & Co. |
| Buy |
| Neutral |
| downgrade |
| 6 Jan 2023 | Piper Sandler | Overweight | Overweight | maintain |
| 21 Nov 2022 | HC Wainwright & Co. | Buy | Buy | maintain |
| 8 Nov 2022 | SVB Leerink | Market Perform | Perform | maintain |
| 19 May 2022 | HC Wainwright & Co. | Buy | Buy | maintain |
| 23 Mar 2022 | SVB Leerink | Market Perform | Perform | maintain |
| 19 Jan 2022 | Goldman Sachs | Buy | Neutral | downgrade |